Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: A survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation

Bone Marrow Transplantation

Volumn 31, Issue 6, 2003, Pages 481-486

  Ljungman, P ^a   Ribaud, P ^b   Eyrich, M ^c   Matthes Martin, S ^d   Einsele, H ^c   Bleakley, M ^e   Machaczka, M ^f   Bierings, M ^g   Bosi, A ^h   Gratecos, N ⁱ   Cordonnier, C ^j  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b SAINT LOUIS HOSPITAL   (France)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^d ST ANNA CHILDREN S HOSPITAL   (Austria)

^e CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^f JAGIELLONIAN UNIVERSITY   (Poland)

^g UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^h University Hospital   (Italy)

ⁱ CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^j HENRI MONDOR HOSPITAL   (France)

more..

Author keywords

Adenovirus; Allogeneic; Cidofovir; Stem cell transplantation

Indexed keywords

CIDOFOVIR; CYCLOSPORIN; IMMUNOGLOBULIN; PROBENECID; TACROLIMUS;

ACUTE GRANULOCYTIC LEUKEMIA; ADENOVIRUS; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BONE MARROW SUPPRESSION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; DEATH; DRUG EFFICACY; DRUG USE; EUROPE; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HEALTH CARE ORGANIZATION; HEALTH SURVEY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IN VITRO STUDY; KIDNEY FAILURE; LIVER DISEASE; MORBIDITY; MORTALITY; MYELODYSPLASTIC SYNDROME; NAUSEA; NEPHROTOXICITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL; SYMPTOM; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT OUTCOME; VIRUS INFECTION;

ADENOVIRUS INFECTIONS, HUMAN; ADOLESCENT; ADULT; ANTIVIRAL AGENTS; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; CYTOSINE; DATA COLLECTION; EUROPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; ORGANOPHOSPHORUS COMPOUNDS; PHOSPHONIC ACIDS; QUESTIONNAIRES; TRANSPLANTATION, HOMOLOGOUS;

EID: 0037366835     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703798     Document Type: Article

References (20)

1. Hale GA, Hestop HE, Krance RA et al. Adenovirus infection after pediatric bone marrow transplantation. Bone Marrow Transplant 1999; 23: 277-282.
2. Howard DS, Phillips GL, Reece DE et al. Adenovirus infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 1999; 29: 1494-1501.
3. Flomenberg P, Babbitt J, Drobyski WR et al. Increasing incidence of adenovirus disease in bone marrow transplant recipients. J Infect Dis 1994; 169: 775-781.
4. Baldwin A, Kingman H, Darville M et al. Outcome and clinical course of 100 patients with adenovirus infection following bone marrow transplantation. Bone Marrow Transplant 2000; 26: 1333-1338.
5. De Clercq E. Therapeutic potential of Cidofovir (HPMPC, Vistide) for the treatment of DNA virus (i.e. herpes-, papova-, pox- and adenovirus) infections. Verh K Acad Geneeskd Belg 1996; 58: 19-47; discussion 47-49.
6. de Oliveira CB, Stevenson D, LaBree L et al. Evaluation of Cidofovir (HPMPC, GS-504) against adenovirus type 5 infection in vitro and in a New Zealand rabbit ocular model. Antivir Res 1996; 31: 165-172.
7. Ljungman P, Deliliers GL, Platzbecker U et al. Cidofovir for cytomegalovirus infection and disease in allogeneic stem cell transplant recipients. The Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Blood 2001; 97: 388-392.
8. La Rosa AM, Champlin RE, Mirza N et al. Adenovirus infections in adult recipients of blood and marrow transplants. Clin Infect Dis 2001; 32: 871-876.
9. Wasserman R, August CS, Plotkin SA. Viral infections in pediatric bone marrow transplant patients. Pediatr Infect Dis J 1988; 7: 109-115.
10. Shields AF, Hackman RC, Fife KH et al. Adenovirus infections in patients undergoing bone-marrow transplantation. N Engl J Med 1985; 312: 529-533.
11. Chakrabarti S, Collingham KE, Fegan CD et al. Fulminant adenovirus hepatitis following unrelated bone marrow transplantation: failure of intravenous ribavirin therapy. Bone Marrow Transplant 1999; 23: 1209-1211.
12. Miyamura K, Hamaguchi M, Taji H et al. Successful ribavirin therapy for severe adenovirus hemorrhagic cystitis after allogeneic marrow transplant from close HLA donors rather than distant donors. Bone Marrow Transplant 2000; 25: 545-548.
13. Mann D, Moreb J, Smith S et al. Failure of intravenous ribavirin in the treatment of invasive adenovirus infection following allogeneic bone marrow transplantation: a case report. J Infect 1998; 36: 227-278.
14. Cassano WF. Intravenous ribavirin therapy for adenovirus cystitis after allogeneic bone marrow transplantation. Bone Marrow Transplant 1991; 7: 247-248.
15. Liles WC, Cushing H, Holt S et al. Severe adenoviral nephritis following bone marrow transplantation: successful treatment with intravenous ribavirin. Bone Marrow Transplant 1993; 12: 409-412.
16. Hromas R, Clark C, Blanke C et al. Failure of ribavirin to clear adenovirus infections in T cell-depleted allogeneic bone marrow transplantation. Bone Marrow Transplant 1994; 14: 663-664.
17. Kapelushnik J, Or R, Delukina M et al. Intravenous ribavirin therapy for adenovirus gastroenteritis after bone marrow transplantation. J Pediatr Gastroenterol Nutr 1995; 21: 110-112.
18. Bordigoni P, Carret AS, Venard V et al. Treatment of adenovirus infections in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 2001; 32: 1290-1297.
19. Ribaud P, Scieux C, Freymuth F et al. Successful treatment of adenovirus disease with intravenous cidofovir in an unrelated stem-cell transplant recipient. Clin Infect Dis 1999; 28: 690-691.
20. Legrand F, Berrebi D, Houhou N et al. Early diagnosis of adenovirus infection and treatment with cidofovir after bone marrow transplantation in children. Bone Marrow Transplant 2001; 27: 621-626.